- Home
- MTVA vs PRZO Comparison
MTVA vs PRZO Comparison
Compare MTVA & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- PRZO
- Stock Information
- Founded
- MTVA 2014
- PRZO 2014
- Country
- MTVA United States
- PRZO Israel
- Employees
- MTVA N/A
- PRZO N/A
- Industry
- MTVA
- PRZO
- Sector
- MTVA
- PRZO
- Exchange
- MTVA NYSE
- PRZO Nasdaq
- Market Cap
- MTVA 13.6M
- PRZO 13.7M
- IPO Year
- MTVA N/A
- PRZO 2023
- Fundamental
- Price
- MTVA $0.78
- PRZO $0.60
- Analyst Decision
- MTVA Strong Buy
- PRZO
- Analyst Count
- MTVA 1
- PRZO 0
- Target Price
- MTVA $12.00
- PRZO N/A
- AVG Volume (30 Days)
- MTVA 1.4M
- PRZO 214.7K
- Earning Date
- MTVA 05-08-2025
- PRZO 03-21-2025
- Dividend Yield
- MTVA N/A
- PRZO N/A
- EPS Growth
- MTVA N/A
- PRZO N/A
- EPS
- MTVA N/A
- PRZO N/A
- Revenue
- MTVA N/A
- PRZO $932,154.00
- Revenue This Year
- MTVA N/A
- PRZO N/A
- Revenue Next Year
- MTVA N/A
- PRZO N/A
- P/E Ratio
- MTVA N/A
- PRZO N/A
- Revenue Growth
- MTVA N/A
- PRZO 50.22
- 52 Week Low
- MTVA $0.71
- PRZO $0.49
- 52 Week High
- MTVA $5.30
- PRZO $3.16
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- PRZO 38.18
- Support Level
- MTVA N/A
- PRZO $0.57
- Resistance Level
- MTVA N/A
- PRZO $0.63
- Average True Range (ATR)
- MTVA 0.00
- PRZO 0.06
- MACD
- MTVA 0.00
- PRZO 0.01
- Stochastic Oscillator
- MTVA 0.00
- PRZO 52.29
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.